切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2015, Vol. 09 ›› Issue (02) : 155 -158. doi: 10.3877/cma.j.issn.1674-0793.2015.02.019

综述

黏着斑激酶与肝癌侵袭、转移的研究进展
刘伟1, 杭春玖1, 薛同敏1, 张培建1,()   
  1. 1.215000 扬州大学第二临床医学院普通外科研究室
  • 收稿日期:2015-02-09 出版日期:2015-04-01
  • 通信作者: 张培建
  • 基金资助:
    江苏省扬州市自然科学基金面上项目(YZ2014064)

Progress on relationship between focal adhesion kinase and invasion metastasis of hepatoma

Wei Liu1, Chunjiu Hang1, Tongmin Xue1, Peijian Zhang1,()   

  1. 1.Institute of General Surgical Research, the Second Affiliated Hospital, Yangzhou University, Yangzhou 225002, China
  • Received:2015-02-09 Published:2015-04-01
  • Corresponding author: Peijian Zhang
引用本文:

刘伟, 杭春玖, 薛同敏, 张培建. 黏着斑激酶与肝癌侵袭、转移的研究进展[J/OL]. 中华普通外科学文献(电子版), 2015, 09(02): 155-158.

Wei Liu, Chunjiu Hang, Tongmin Xue, Peijian Zhang. Progress on relationship between focal adhesion kinase and invasion metastasis of hepatoma[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2015, 09(02): 155-158.

黏着斑激酶(FAK)是一种位于胞质内的非受体酪氨酸激酶,在细胞、胚胎、器官发育中发挥重要的生物学功能,同时与肿瘤的发生、发展关系密切。 本文就FAK 与肝癌的侵袭、转移的研究进展作一综述。

Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase located within the cytoplasm and plays an important biological role in cell, embryon and organ development. Meanwhile, it is closely related to the onset and development of tumor. This article reviews the progress on invasion and metastasis between FAK and hepatoma.

1
Shieh JM, Cheng TH, Shi MD, et al. A-tomatine suppresses invasion and migration of human non-small cell lung cancer NCIH460 cells through inactivity of NF-Jb[J]. Cell Biochem Biophys,2011, 60(1): 297-310.
2
Luo M, Guan JL. Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis[J]. Cancer Lett, 2010, 289(2): 127-139.
3
Hayasaka H, Martin KH, Hershey ED, et al. Disruption of FRNK expression by gene targeting of the intronic promoter within the focal adhesion kinase gene[J]. J cell Biochem, 2007, 102(4): 947-954.
4
Hiratsuka S, Goel S, Kamoun WS, et al. Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation[J]. Proc Natl Acad Sci USA,2011, 108(9): 3725-3730.
5
Zhao X, Guan JL. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis[J]. Adv Drug Deliv Rev,2011, 63(8): 610-615.
6
Carelli S, Zadra G, Vaira V, et al. Up-regulation of focal adhesion kinase in non-small cell lung cancer[J]. Lung Cancer, 2006,53(3): 263-271.
7
Mitra S K, Lin ST, Chi A, et al. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model[J]. Oncogene, 2006, 25(32): 4429-4440.
8
Halder J, Kamat AA, Landen CN Jr, et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy[J]. Clin Cancer Res,2006, 12(16): 4916-4924.
9
Pylayeva Y, Gillen KM , Gerald W, et al. Ras-and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling[J]. J Clin Invest, 2009, 119(2): 252-266.
10
Lee J, Borboa AK, Chun HB, et al. Conditional deletion of the focal adhesion kinase FAK alters remodeling of the blood-brain barrier in glioma[J]. Cancer Res, 2010, 70(24): 10131-10140.
11
Huang AL, Wan Y, Liao DY, et al. Suppression of human MDAMB-435S tumor by U6 promoter-driven short hairpin RNAs targeting focal adhesion kinase[J]. J Cancer Res Clin Oncol, 2010,136(8): 1229-1242.
12
Stokes JB, Adair SJ, Slack-Davis JK, et al. Inhibition of focal adhesion kinase by PF-562, 271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment[J]. Mol Cancer Ther, 2011, 10(11): 2135-2145.
13
Boosani CS, Nalabothula N, Munugalavadla V, et al. FAK and p38-MAPK kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by alphal (IV) NC1[J]. Invest Ophthalmol Vis Sci, 2009, 50(10): 4567-4575.
14
Bateman NW, Sun M, Hood BL, et al. Defining central themes in breast cancer biology by differential proteomics: conserved regulation of cells spreading and focal adhesion kinase[J]. J Proteome Res, 2010, 9(10): 5311-5324.
15
Wendt MK, Smith JA, Schiemann WP. Transforming growth factor-beta-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression[J].Oneogene, 2010, 29(49): 6485-6498.
16
Mclean GW, Carragher NO, Avizienyte E, et al. The role of focaladhesion kinase in cancer. A new therapeutic opportunity[J]. Nat Rev Cancer, 2005, 5(7): 505-515.
17
Luo M, Guan JL. Focal adhesion kinase: A prominent determinant in breast cancer initiation, progression and metastasis[J]. Cancer Lett, 2010, 289(2): 127-139.
18
张学彦, 吕成倩, 杜冰, 等. FAK 在食管癌组织中的表达及临床意义[J]. 胃肠病学和肝病学杂志, 2014, 23(8): 866-869.
19
台令华, 于东红, 柯桥利. FAK 在胃癌组织中的表达及与Hp-L型感染的关系[J]. 中国组织化学与细胞化学杂志, 2014, 23(4):325-330.
20
杨甜, 常圆, 关锦明. FAK 与消化系统肿瘤相关性的研究进展[J]. 胃肠病学和肝病学杂志, 2013, 22(3): 280-282.
21
Sood AK, Coffin JE, Schneider GB, et al. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion[J]. Am J Pathol, 2004 ,165(4): 1087-1095.
22
任芳, 史惠蓉, 刘惠娜, 等. 肝癌缺失基因-1 和黏着斑激酶基因对肿瘤OVCAR-3 细胞增殖和凋亡的影响[J]. 中华实验外科杂志, 2013, 30(4): 814-817.
23
李匡凡, 杨真真, 李勇. 黏着斑激酶和磷酸酶基因蛋白在肝细胞癌中的表达及意义[J]. 广东医学, 2014 , 35(14): 2216-2219.
24
Frau M, Biasi F, Feo F, et al. Prognostic markers and putative therapeutic targets for hepatic carcinoma[J]. Mol Aspects Med,2010, 31 (24): 179-193.
25
范建, 杨华英, 孙冬霞, 等. uPA 和FAK 在肝癌组织中的表达及相关性研究[J]. 现代中西医结合杂志,2013,22(6):589-590,593.
26
陈连周, 刘敏, 欧阳文婷, 等. 黏着斑激酶在肝细胞肝癌中的表达及其与预后的关系[J]. 中国医药, 2010, 5(1): 9-10.
27
韩少山, 刘青光, 周振宇,等. FAK 在肝癌组织中的表达及临床病理意义[J]. 西安交通大学学报, 2013, 34(1): 81-84, 127.
28
Golubovskaya VM, Sumbler B, Ho B, et al. MiR-138 and MiR-135 directly target focal adhesion kinase, inhibit cell invasion,and increase sensitivity to chemotherapy in cancer cells[J]. Anticancer Agents Med Chem, 2014, 14(1): 18-28.
29
袁周, 郑起, 黄新余, 樊嘉. 抑制黏着斑激酶表达对人肝癌细胞转移潜能的作用[J]. 中华外科杂志, 2007, 45 (19): 1350-1353.
30
胡炜, 王嵬, 高振宇. 硼替佐米体外对前列腺癌细胞迁移和侵袭的影响及其机制[J]. 肿瘤研究与临床, 2014 , 26(2): 98-101.
31
Ou J, Pan F, Geng P, et al. Silencing fibronectin extra domain A enhances radiosensitivity in nasopharyngeal carcinomas involving an FAK/Akt/JNK pathway[J]. Int J Radiat Oncol Biol Phys, 2012,82(4): e685-e691.
32
Zhao X, Guan JL. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis[J]. Adv Drug Deliv Rev,2011, 63(8): 610-615.
[1] 闫泽辉, 狄靖凯, 郭子瑊, 穆昶江, 张智博, 陈帅, 王泽华, 田最, 向川. 膝关节机械感受器在半月板损伤中的功能[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 524-531.
[2] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[3] 高金红, 陈玉梅, 郭韵. 基于King互动达标理论的心理疏导在腹腔镜肝癌切除术患者的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 517-520.
[4] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[5] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[6] 胡宁宁, 赵延荣, 王栋, 王胜亮, 郭源. FMNL3与肝细胞癌肝移植受者预后的相关性研究[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 283-288.
[7] 王飞, 陈政, 余德才, 曹亚娟. 原发性肝癌合并门静脉高压症的微创手术治疗[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 306-310.
[8] 张敏, 朱建华, 缪雅芳, 郭锦荣. 菝葜皂苷元对肝癌HepG2细胞抑制作用的机制研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 328-335.
[9] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[10] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[11] 吴孝琦, 罗飞, 史凡凡, 方青. 移动健康在慢性肌肉骨骼疼痛患者自我管理中的应用进展[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(04): 251-256.
[12] 广东省护士协会介入护士分会, 广东省医师协会介入医师分会. 原发性肝癌低血糖患者护理规范管理专家共识[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 709-714.
[13] 韦巧玲, 黄妍, 赵昌, 宋庆峰, 陈祖毅, 黄莹, 蒙嫦, 黄靖. 肝癌微波消融术后中重度疼痛风险预测列线图模型构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 715-721.
[14] 蔡晓雯, 李慧景, 丘婕, 杨翼帆, 吴素贤, 林玉彤, 何秋娜. 肝癌患者肝动脉化疗栓塞术后疼痛风险预测模型的构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 722-728.
[15] 周微薇, 罗宇, 何朝晖. 解释消化内镜在职护士培训的现实主义整合[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(04): 276-281.
阅读次数
全文


摘要